EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Diagnostic Accuracy of a Novel Point of Care High‐Sensitivity Troponin Assay in the Prehospital Environment

John Gilman, Abdulrhman Alghamdi iD, Mark Hann, Edward Carlton, Jamie G Cooper, Eloïse Cook, Aloysius Niroshan Siriwardena, John Phillips, Alexander Thompson iD, Steve Bell iD, Kim Kirby, Andy Rosser und 1 weitere

Academic Emergency Medicine · 2026-01 · 33 (1)

DOI: 10.1111/acem.70213 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Academic Emergency Medicine, online erschienen am 13.01.2026. Verfasst von John Gilman und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Northern Care Alliance NHS Foundation Trust, Salford, UK. Hauptthemen laut MEDLINE: Emergency Medical Services, Myocardial Infarction, Point-of-Care Systems, Troponin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research, Abbott Point of Care.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the diagnostic accuracy of a novel point of care (POC) high‐sensitivity troponin (hs‐cTn) assay, used alone or incorporated within validated decision aids, for acute myocardial infarction (AMI) in the prehospital setting.

Methods

A pre‐specified secondary analysis of the Prehospital Evaluation of Sensitive Troponin (PRESTO) prospective diagnostic accuracy study, conducted in four ambulance services and 12 Emergency Departments (EDs; February 2019–March 2020). Paramedics included consenting adults with suspected AMI and no other reason for conveyance. Clinical data and venous blood were collected at the scene, and samples conveyed to hospital with participants. Plasma samples were later analyzed for hs‐cTn using a novel POC hs‐cTn assay (Abbott Point of Care i‐STAT hs‐TnI). The target condition was an adjudicated index diagnosis of type 1 AMI.

Results

Of 817 consenting participants, 704 were eligible for inclusion in this analysis, with type 1 AMI occurring in 89 (12.6%). At the limit of detection (< 2 ng/L), POC hs‐cTn had 100.0% sensitivity (95% CI 95 9%–100.0%) but only 4.6% specificity (95% CI 3.1%–6.5%). A Troponin‐only Manchester Acute Coronary Syndromes (T‐MACS) very‐low risk outcome identified 134 (19.7%) patients for non‐conveyance with 98.9% sensitivity (95% CI 94.9%–100.0%), 99.3% negative predictive value (NPV, 95% CI 95.0%–99.9%), and 22.5% specificity (95% CI 19.2%–26.1%). A low‐risk modified HEART score identified 150 (22.0%) patients with 93.2% sensitivity (95% CI 85.8%–97.5%), 96.0% NPV (91.6%–98.1%), and 24.3% specificity (95% CI 20.9%–27.9%). In an exploratory analysis, hs‐cTn < 5 ng/L identified 295 (41.9%) patients with 98.9% sensitivity (93.9%–100.0%), 99.7% NPV (97.7%–100.0%), and 47.8% specificity (95% CI 43.8%–51.8%).

Conclusions

This novel POC hs‐cTn assay achieves high sensitivity and NPV when used alongside the T‐MACS decision aid, but efficiency may be greater at a 5 ng/L threshold without requiring any decision aid. Trial Registration ClinicalTrials.gov identifier: NCT03561051

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Emergency Medical ServicesMyocardial InfarctionPoint-of-Care SystemsTroponinAdultAgedFemaleHumansMaleMiddle AgedBiomarkersEmergency Service, HospitalProspective StudiesSensitivity and Specificity

Stichwörter der Autor:innen

acute coronary syndromesacute myocardial infarctiondiagnosisemergency medical serviceshigh sensitivity troponinsprehospital caresensitivity and specificitytroponins

Substanzen

BiomarkersTroponin

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Northern Care Alliance NHS Foundation Trust, Salford, UK.
  • College of Applied Medical Sciences, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Division of Population Health, Health Services Research & Primary Care, the University of Manchester, Manchester, UK.
  • University of Bristol Medical School, Translational Health Sciences, Southmead Hospital Learning and Research, Bristol, UK.
  • Emergency Department, Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, UK.

ORCID-Profile: Abdulrhman Alghamdi, Alexander Thompson, Steve Bell

Förderung

  • National Institute for Health and Care Research
  • Abbott Point of Care

Zitieren

APA

Gilman, J., Alghamdi, A., Hann, M., Carlton, E., Cooper, J. G., Cook, E., Siriwardena, A. N., Phillips, J., Thompson, A., Bell, S., Kirby, K., Rosser, A., & Body, R. (2026). Diagnostic Accuracy of a Novel Point of Care High‐Sensitivity Troponin Assay in the Prehospital Environment. Academic Emergency Medicine, 33(1). https://doi.org/10.1111/acem.70213

Vancouver

Gilman J, Alghamdi A, Hann M, Carlton E, Cooper JG, Cook E, et al. Diagnostic Accuracy of a Novel Point of Care High‐Sensitivity Troponin Assay in the Prehospital Environment. Academic Emergency Medicine. 2026;33(1). doi:10.1111/acem.70213

BibTeX
@article{Gilman2026,
  author = {Gilman, John and Alghamdi, Abdulrhman and Hann, Mark and Carlton, Edward and Cooper, Jamie G and Cook, Eloïse and Siriwardena, Aloysius Niroshan and Phillips, John and Thompson, Alexander and Bell, Steve and Kirby, Kim and Rosser, Andy and Body, Richard},
  title = {Diagnostic Accuracy of a Novel Point of Care High‐Sensitivity Troponin Assay in the Prehospital Environment},
  journal = {Academic Emergency Medicine},
  year = {2026},
  volume = {33},
  number = {1},
  doi = {10.1111/acem.70213}
}
Kostenlos starten →